mayerPresented by:
Lori L. Mayer, RN, MSN, MSCN, CCRP
Director of Medical Research Services
MS Clinic of Central Texas
Central Texas Neurology Consultants
Round Rock, Texas



Play

CME/CE Information

Activity Title Strategies to Identify and Address Barriers to Patient Adherence to MS Therapies
Topic Multiple Sclerosis
Accreditation Type AMA PRA Category 1 Credit™/Continuing Education Credits
Release Date May 2013
Expiration Date May 30, 2014 – No longer available for credit
Estimated Time to Complete Activity 30 minutes

LEARNING OBJECTIVES

Upon completion of the activity, participants should be able to:

  • Implement strategies for the identification of barriers to patient adherence and develop management strategies that incorporate patient and family education to address these barriers and improve adherence

FACULTY

Lori L. Mayer, RN, MSN, MSCN, CCRP
Director of Medical Research Services
MS Clinic of Central Texas
Central Texas Neurology Consultants
Round Rock, Texas

METHOD OF PARTICIPATION / HOW TO RECEIVE CREDIT

  1. There are no fees for participating in and receiving credit for this activity.
  2. Review the activity objectives and CME/CE information.
  3. Complete the CME/CE activity.
  4. Complete the posttest. A score of at least 75% is required to successfully complete this activity. The participant may take the test until successfully passed.
  5. Complete the CME/CE evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice, the perception of commercial bias, and whether or not the objectives were met.
  6. Your CME/CE certificate will be available for download

CLICK HERE TO VIEW TECHNICAL REQUIREMENTS


SPONSOR

Sponsored through an educational collaboration by the Consortium of Multiple Sclerosis Centers, The France Foundation, and Nurse Practitioner Alternatives.


TARGET AUDIENCE

This activity is intended for neurologists, neurology nurse practitioners, neurology physician assistants, neurology nurses, and other health care providers involved in the management of patients with MS.


STATEMENT OF NEED

The continued prevalence of MS and the current and ongoing advances in the diagnosis and management of the disease inevitably create knowledge and performance gaps for neurologists and other health care providers who care for patients with MS. To address the identified educational needs of these providers, the Consortium of Multiple Sclerosis Centers (CMSC), Nurse Practitioner Alternatives (NPA), and The France Foundation have created the AIMS (Advances In Multiple Sclerosis) Curriculum. This curriculum is designed to provide high-quality, up-to-date information on advances in the treatment of MS.


ACCREDITATION STATEMENT

Consortium of Multiple Sclerosis Centers (CMSC) and The France Foundation are accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Nurse Practitioner Alternatives is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Nurse Practitioner Alternatives awards 0.5 contact hours of continuing nursing education for RNs and APRNs.

Laurie Scudder DNP, NP, has served as Nurse Planner for this activity.


CREDIT DESIGNATION

Physicians
The Consortium of Multiple Sclerosis Centers (CMSC) designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Accreditation does not imply endorsement by NPA, CMSC, The France Foundation, or ANCC of recommendations or any commercial products displayed or discussed in conjunction with the educational activity.


RESOLUTION OF CONFLICTS OF INTEREST

In accordance with the ACCME Standards for Commercial Support of CME, The Consortium of Multiple Sclerosis Centers, The France Foundation, and Nurse Practitioner Alternatives will implement mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.


DISCLOSURES

It is the policy of The Consortium of Multiple Sclerosis Centers, The France Foundation, and Nurse Practitioner Alternatives to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty, activity planners, content reviewers, and staff participating in this activity have disclosed to the participants any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The Consortium of Multiple Sclerosis Centers, The France Foundation, and Nurse Practitioner Alternatives have identified and resolved any and all conflicts of interest prior to the release of this activity.


Activity Staff Disclosures

The following planners, reviewers, editors, staff, Continuing Professional Education committee, or other members at The Consortium of Multiple Sclerosis Centers who control content have no relevant financial relationships to disclose.

  • Tina Trott

The following planners, reviewers, editors, staff, Continuing Professional Education committee, or other members at The Consortium of Multiple Sclerosis Centers who control content have relevant financial relationships to disclose.

  • June Halper, MSN, ANP, FAAN, is a consultant for Acorda Therapeutics and a speaker for non-CME programs for Acorda Therapeutics.

The planners, reviewers, editors, staff, CME committee, or other members at Nurse Practitioner Alternatives who control content have no relevant financial relationships to disclose.

The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.


Content Faculty Disclosure

The following faculty have indicated they have relationships with industry to disclose relative to the content of this CME/CNE activity:

  • Edward J. Fox, MD, PhD, has received grant support from Biogen Idec, Eli Lilly, EMD Serono, Genzyme, GlaxoSmithKline, Novartis, Prexa, Roche, Sanofi Aventis, and Teva. He has served as a consultant for Biogen Idec, Genzyme, Novartis, Prexa, and Teva. He has received honoraria from Acorda Therapeutics, Bayer, Biogen Idec, EMD Serono, Genzyme, Novartis, Sanofi Aventis, and Teva. He has received other financial support from the National Multiple Sclerosis Society.
  • Lori L. Mayer, RN, MSN, MSCN, CCRP, has received grant support from Biogen Idec, GlaxoSmithKline, International Organization of Multiple Sclerosis Nurses (IOMSN), Innovative Electronics, ONO Pharmaceuticals, Roche, Sanofi US Services, and Teva Neuroscience. She has served as a consultant and received honoraria from Acorda Therapeutics, Biogen Idec, EMD Serono, Questcor Pharmaceuticals, Sanofi US Services, and Teva Neuroscience.

Activity Faculty Disclosure

The following faculty has indicated he has relationships with industry to disclose relative to the content of this CME/CNE activity:

  • Lori L. Mayer, RN, MSN, MSCN, CCRP, has received grant support from Biogen Idec, GlaxoSmithKline, International Organization of Multiple Sclerosis Nurses (IOMSN), Innovative Electronics, ONO Pharmaceuticals, Roche, Sanofi US Services, and Teva Neuroscience. She has served as a consultant and received honoraria from Acorda Therapeutics, Biogen Idec, EMD Serono, Questcor Pharmaceuticals, Sanofi US Services, and Teva Neuroscience.

UNAPPROVED USE DISCLOSURE

The Consortium of Multiple Sclerosis Centers, The France Foundation and Nurse Practitioner Alternatives require CME/CNE faculty (speakers) to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.


COMMERCIAL SUPPORT ACKNOWLEDGMENT

This activity is supported by educational grants from EMD Serono, Novartis, and Teva.


DISCLAIMER

The Consortium of Multiple Sclerosis Centers, The France Foundation, and Nurse Practitioner Alternatives present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The Consortium of Multiple Sclerosis Centers, The France Foundation, Nurse Practitioner Alternatives, EMD Serono, Novartis, and Teva assume no liability for the information herein.


COPYRIGHT INFORMATION

Copyright © 2013 The Consortium of Multiple Sclerosis Centers, The France Foundation, and Nurse Practitioner Alternatives. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions: :

  • The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
  • Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without The France Foundation's prior written permission.

PRIVACY POLICY

The Consortium of Multiple Sclerosis Centers, The France Foundation, and Nurse Practitioner Alternatives protect the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.

The Consortium of Multiple Sclerosis Centers, The France Foundation, and Nurse Practitioner Alternatives maintain physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.

Additional information regarding The France Foundation's Privacy Policy can be viewed at http://www.francefoundation.com/privacy.


CONTACT INFORMATION

If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or This email address is being protected from spambots. You need JavaScript enabled to view it..


 

 

Play

 

Access other Therapeutic Areas:


 

Latest CME/CNE Education

  • Targeting B-cells in Primary Progressive MS (PPMS)


    Read More
  • Vitamin D: Modifiable Risk Factor and its Role in the Management of Patients with MS


    Read More
  • The Gut Microbiota in MS


    Read More